Viewing Study NCT05751018


Ignite Creation Date: 2025-12-25 @ 4:48 AM
Ignite Modification Date: 2026-01-22 @ 9:07 AM
Study NCT ID: NCT05751018
Status: RECRUITING
Last Update Posted: 2025-12-02
First Post: 2023-02-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Clinical Study of Pyrotinib in First-line Treatment of Primary HER2-amplified/Mutated Advanced Non-small Cell Lung Cancer
Sponsor: Peking Union Medical College Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module